Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/6613
Title: | Is the anti-sarcoma and anti-viral cytokine “plasma factor” a novel chicken Y-box protein? |
Authors: | Shirodkar, Manohar V N Sehgal, Pravin B |
Keywords: | Anti-sarcoma;Cytokine;Plasma factor;Y-box protein |
Issue Date: | Oct-2006 |
Publisher: | CSIR |
Abstract: | A line of research beginning in the early 1960s with the observation that West Nile virus and, later, several strains of rabies virus could inhibit the development of the Rous sarcoma virus-induced tumor in the wing-web of chicken (a “sarcoma-blockade”) eventually culminated in the characterization of a 14-kDa circulating anti-sarcoma and anti-viral activity christened “plasma factor” (PF) which, unlike the interferons, inhibited the replication of diverse RNA-containing viruses, but not of any DNA-containing viruses. The possibility that this 14 kDa protein represented a novel antiviral cytokine has been strengthened by analysis of partial amino acid sequencing data which suggest that this 14-kDa cytokine may correspond to the 127-amino acid-long chicken YB2-like protein (Locus: XP_423576) deduced very recently from the genomic sequencing of chicken. Biologically, proteins of the Y-box family (such as chicken YB1 and YB2) not only bind DNA and thus regulate transcription but also bind single-stranded RNA in a sequence-specific and reversible manner, repress viral RNA translation, inhibit retroviral transformation of chicken fibroblasts, and are known to regulate transcription of human immunodeficiency virus and hepatitis B virus. Taken together, the available data point to a novel anti-viral cytokine with a novel mechanism of action. |
Page(s): | 777-782 |
ISSN: | 0975-1009 (Online); 0019-5189 (Print) |
Appears in Collections: | IJEB Vol.44(10) [October 2006] |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
IJEB 44(10) 777-782.pdf | 143.9 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.